The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Press Commentary

28 Oct 2022 07:00

RNS Number : 4301E
Bidstack Group PLC
28 October 2022
 

28 October 2022

Bidstack Group Plc

("Bidstack" or the "Company" or the "Group")

Update re Press Commentary

Further to the Company's strategy update to the market on 26 October 2022, the Board notes recent press commentary regarding a private communication by the Company with certain investors concerning an email received from Azerion, which the Directors have been advised did not require disclosure under either the AIM Rules or MAR. In order to ensure that all shareholders have parity of information the Company wishes to give this update.

After the announcement on 5 October 2022 of the Group's Fundraise, Bidstack received an email from Azerion requesting certain information and reserving its rights under the Azerion agreement.

Given the nature of the Group's strong ongoing commercial relationship with Azerion and the extensive work taking place on the ground to ensure the success of the partnership by both Azerion and Bidstack, the Directors were surprised to receive this email.  At a commercial level, the Group's arrangements with Azerion continue to be operated on a 'business as usual' basis by both parties, with October already the highest grossing month to date and with November and December anticipated to grow further month on month. Bidstack has responded with detailed information demonstrating the Group's compliance with all areas identified. Bidstack has taken appropriate external legal advice and has concluded that Azerion has no present entitlement to end its agreement with the Group.

As referred to in the Company's announcement on 26 October 2022, following early evidence of its success in selling directly into North America and Japan, Bidstack intends to undertake a comprehensive business review, specifically reassessing and renegotiating, where appropriate, both existing and new reseller engagements in all geographies in order to maximise the benefits of its contacts with developers, publishers, ad-tech vendors and media companies.

Bidstack notes that Azerion is primarily a European-based group, with its sales-reach strongest in these territories. As announced on 20 September and 13 and 26 October, Bidstack has now invested in an experienced sales team with a proven track record in North America, which has a robust pipeline for FY23.

Bidstack's newly appointed Group Chief Revenue Officer is in active discussions on a number of significant global revenue opportunities, including additional resellers, licensors and media agreements, with anticipated contracts in FY23.

The Company would like to stress that, contrary to the press commentary, there is no litigation with Azerion, and the contract with Azerion continues to operate as expected.

The Directors also confirm that there are no discussions with Azerion regarding any offer for the Company.

The Board believes that the Company is trading in line with market expectations for the years ended 31 December 2022 and 2023.

-ENDS-

Contacts

Bidstack Group Plc

James Draper, CEO

 

via Buchanan

SPARK Advisory Partners Limited (Nomad)

Mark Brady / Neil Baldwin / James Keeshan

 

+44 (0) 203 368 3550

Stifel Nicolaus Europe Limited (Broker)

Fred Walsh / Tom Marsh

 

+44 (0) 20 7710 7600

Buchanan Communications Limited

Chris Lane / Stephanie Whitmore / Kim van Beeck

bidstack@buchanan.uk.com

 

+44 (0) 20 7466 5000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFIFEIILLTFIF
Date   Source Headline
28th Oct 201412:03 pmRNSStatement re Share Price
22nd Oct 20147:00 amRNSFitbug to be stocked by Target and Sainsbury's
30th Sep 20147:00 amRNSInterim Results
29th Jul 20147:00 amRNSSecures £1,750,000 Loan on Attractive Terms
26th Jun 20147:00 amRNSResult of AGM
29th May 20147:00 amRNSFinal Results
30th Apr 201412:00 pmRNSLoan Update
23rd Apr 20147:00 amRNSAppointment of CEO & US Retail Representative
26th Mar 20147:00 amRNSAppointed Group Sales Director & 6 Retail Partners
11th Feb 20147:00 amRNSLaunch of Fitbug KiK Plan and £1,000,000 Loan
11th Dec 20137:00 amRNSSecures £1,000,000 Loan on Attractive Terms
21st Oct 20137:00 amRNSCommercial Launch of Fitbug Orb
20th Sep 20137:00 amRNSInterim Results
10th Sep 20137:00 amRNSEntry into Australian Market - MSA with Leap4Life
15th Aug 20137:00 amRNSEntry into Asian Markets - Launch of AIA Vitality
27th Jun 20133:30 pmRNSResult of AGM
20th Jun 20137:00 amRNSJoin leading US health insurer's CarePass Platform
31st May 20137:00 amRNSFinal Results and Notice of AGM
9th Apr 20137:00 amRNSSecures £750,000 Loan on Attractive Terms
12th Mar 201311:45 amRNSChange of Adviser
7th Mar 20137:00 amRNSSigns Partnership Deals with 3 Leading Businesses
28th Jan 20137:00 amRNSSecures £500,000 Loan on Attractive Terms
9th Jan 20137:00 amRNSLaunch 3 New Products at Consumer Electronic Show
27th Sep 20127:00 amRNSInterim Results
17th Sep 20127:00 amRNSLaunches Fitbug Air
16th Jul 20127:00 amRNSTwo New US Sales Worth US $500,000
2nd Jul 20127:00 amRNSIssue of Convertible Loan Note & Director Dealings
26th Jun 20123:45 pmRNSResult of AGM
15th Jun 20127:00 amRNSAppointment of Joint Broker
11th Jun 20127:00 amRNSLaunch of New Games Framework and iPhone App
31st May 20127:00 amRNSFinal Results and Notice of AGM
9th May 20127:00 amRNSAppointed Activity Tracking Partner in US
20th Mar 20127:00 amRNSGrowth in France and Launch of Product in Germany
20th Feb 20127:00 amRNSAgreement with Major US Health Insurer & Placing
21st Oct 20117:00 amRNSSigns Agreement With MeYou Health
3rd Oct 20117:00 amRNSThree Actions to Support and Accelerate US Growth
22nd Sep 20117:00 amRNSInterim Results
5th Sep 20117:00 amRNSAgreement with Leading US Health Insurer
20th Jul 20112:40 pmRNSResult of AGM
19th Jul 20117:00 amRNSPlacing to raise GBP770,000
27th Jun 20117:00 amRNSFinal Results and Notice of AGM
14th Jun 20117:00 amRNSFour New Deals
23rd May 20117:00 amRNSAgreement - S. Africa Private Medical Insurer
13th Apr 20117:00 amRNSGrant of Options & Conversion of Outstanding Debt
11th Apr 20117:00 amRNSAppointment of Executive Chairman
21st Mar 20117:00 amRNSHolding in Company & Directors' Interests
4th Feb 20117:00 amRNSAppointment of Joint Broker
9th Nov 20105:27 pmRNSHolding(s) in Company
19th Oct 20107:00 amRNSPlacing to raise ?600,000 and trading update
4th Oct 20107:00 amRNSStrategic Partnership with SCIFIT and Patterson

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.